Ceftaroline 600 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 600 mg

Reference Brands: Teflaro (USA), Zinforo (EU)

Category: Antibiotics

Ceftaroline fosamil 600 mg injection is a fifth-generation cephalosporin active against MRSA, used for complicated skin infections and community-acquired pneumonia. Reference brands are Teflaro (US) and Zinforo (EU). Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.

Product Description:

Ceftaroline fosamil is a prodrug cephalosporin, converted in plasma to active ceftaroline. It is the member of the cephalosporin family that does something the others cannot: it binds penicillin-binding protein 2a, the altered PBP that makes Staphylococcus aureus methicillin-resistant. That gives a beta-lactam with genuine MRSA activity, alongside conventional cover against streptococci including S. pneumoniae and many Enterobacterales.

Approved uses are acute bacterial skin and skin structure infection and community-acquired bacterial pneumonia. It is important to be clear about what it does not cover: it has no useful activity against Pseudomonas aeruginosa, is hydrolysed by extended-spectrum beta-lactamases and carbapenemases, and is not an answer to resistant Gram-negative infection.

Sourcing notes. Confirm the current WHO AWaRe classification before using it in tender documentation — anti-MRSA agents sit at the restricted end and institutional buyers increasingly require the category to be stated. Patent position varies by market, with generic entry under way in some. Sterile powder for reconstitution, standard cephalosporin manufacture.